Zhang Xin,Sui Wenyuan.Diagnosis and treatment of neurofibromatosis type 1 associated with severe spinal deformity:a literature review[J].Journal of Clinical Pediatric Surgery,2025,(04):326-330.[doi:10.3760/cma.j.cn101785-202501060-005]
Click Copy

Diagnosis and treatment of neurofibromatosis type 1 associated with severe spinal deformity:a literature review

References:

[1] Lee TSJ,Chopra M,Kim RH,et al.Incidence and prevalence of neurofibromatosis type 1 and 2:a systematic review and meta-analysis[J].Orphanet J Rare Dis,2023,18(1):292.DOI:10.1186/s13023-023-02911-2.
[2] Zhu BY,Zheng TT,Wang W,et al.Genotype-phenotype correlations of neurofibromatosis type 1:a cross-sectional study from a large Chinese cohort[J].J Neurol,2024,271(4):1893-1900.DOI:10.1007/s00415-023-12127-w.
[3] Toro G,Santoro C,Ambrosio D,et al.Natural history of scoliosis in children with NF1:an observation study[J].Healthcare (Basel),2021,9(7):881.DOI:10.3390/healthcare9070881.
[4] Suresh KV,Xu AL,Groves ML,et al.Spinal screening,malignancy,medical therapy,and surgical correction of deformity in pediatric patients with neurofibromatosis type 1:a systematic review[J].J Pediatr Orthop B,2022,31(6):572-582.DOI:10.1097/BPB.0000000000000961.
[5] Habeshian K,Saadeh-Haddad R,DeKlotz C.Plexiform neurofibromas in twins with neurofibromatosis type 1[J].J Am Acad Dermatol,2017,76(6,Supplement 1):AB200.DOI:10.1016/j.jaad.2017.04.779.
[6] Hu ZS,Liu Z,Qiu Y,et al.Morphological differences in the vertebrae of scoliosis secondary to neurofibromatosis type 1 with and without paraspinal neurofibromas[J].Spine (Phila Pa 1976),2016,41(7):598-602.DOI:10.1097/BRS.0000000000001455.
[7] Nguyen R,Dombi E,Akshintala S,et al.Characterization of spinal findings in children and adults with neurofibromatosis type 1 enrolled in a natural history study using magnetic resonance imaging[J].J Neurooncol,2015,121(1):209-215.DOI:10.1007/s11060-014-1629-5.
[8] 杨阳,王升儒,林莞锋,等.一期单纯后路矫形融合治疗Ⅰ型神经纤维瘤病伴营养不良型脊柱侧后凸1例报道[J].中华骨与关节外科杂志,2019,12(4):298-303.DOI:10.3969/j.issn.2095-9958.2019.04.013. Yang Y,Wang SR,Lin WF,et al.One-stage posterior-only approach for dystrophic scoliosis secondary to neurofibromatosis typeⅠ[J].Chin JBone Joint Surg,2019,12(4):298-303.DOI:10.3969/j.issn.2095-9958.2019.04.013.
[9] Tamura R.Current understanding of neurofibromatosis type 1,2,and schwannomatosis[J].Int J Mol Sci,2021,22(11):5850.DOI:10.3390/ijms22115850.
[10] 祁新禹,张学军,白云松,等.凸侧短段固定凹侧生长棒技术治疗小儿神经纤维瘤病脊柱侧弯[J].临床小儿外科杂志,2015,14(4):271-274.DOI:10.3969/j.issn.1671-6353.2015.04.005. Qi XY,Zhang XJ,Bai YS,et al.Treating scoliosis caused by neurofibromatosis with brief fixing on convex side combined with growing rod on concave side[J].DOI:10.3969/j.issn.1671-6353.2015.04.005.
[11] Mao SH,Li S,Ma YY,et al.How to rectify the convex coronal imbalance in patients with unstable dystrophic scoliosis secondary to type I neurofibromatosis:experience from a case series[J].BMC Musculoskelet Disord,2022,23(1):368.DOI:10.1186/s12891-022-05321-w.
[12] Tsirikos AI,Dhokia R,Wordie S.Rotatory dislocation of the spine in dystrophic kyphoscoliosis secondary to neurofibromatosis type 1[J].J Cent Nerv Syst Dis,2018,10:1179573518819484.DOI:10.1177/1179573518819484.
[13] Moodley M,Lopez KR.Neurofibromatosis type 1-an update[J].Semin Pediatr Neurol,2024,52:101172.DOI:10.1016/j.spen.2024.101172.
[14] Shao XX,Huang ZF,Yang JF,et al.Efficacy and safety for combination of t-EMG with O-arm assisted pedicle screw placement in neurofibromatosis type I scoliosis surgery[J].J Orthop Surg Res,2021,16(1):731.DOI:10.1186/s13018-021-02882-9.
[15] Park BJ,Hyun SJ,Wui SH,et al.Surgical outcomes and complications following all posterior approach for spinal deformity associated with neurofibromatosis type-1[J].J Korean Neurosurg Soc,2020,63(6):738-746.DOI:10.3340/jkns.2019.0218.
[16] Wang ZC,Zhang X,Li CY,et al.Safety,pharmacokinetics and efficacy of selumetinib in Chinese adult and paediatric patients with neurofibromatosis type 1 and inoperable plexiform neurofibromas:the primary analysis of a phase 1 open-label study[J].Clin Transl Med,2024,14(3):e1589.DOI:10.1002/ctm2.1589.
[17] Jackson S,Baker EH,Gross AM,et al.The MEK inhibitor selumetinib reduces spinal neurofibroma burden in patients with NF1 and plexiform neurofibromas[J].Neurooncol Adv,2020,2(1):vdaa095.DOI:10.1093/noajnl/vdaa095.

Memo

收稿日期:2025-2-24。
基金项目:国家自然科学基金(82472389、82002918)
通讯作者:隋文渊,Email:suiwenyuan@hotmail.com

Last Update: 2025-04-28